A detailed history of American National Bank transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, American National Bank holds 1,689 shares of EW stock, worth $114,446. This represents 0.01% of its overall portfolio holdings.

Number of Shares
1,689
Previous 1,689 -0.0%
Holding current value
$114,446
Previous $156,000 28.85%
% of portfolio
0.01%
Previous 0.02%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

Apr 25, 2023

SELL
$74.26 - $84.51 $2,821 - $3,211
-38 Reduced 2.2%
1,689 $139,000
Q4 2022

Jan 10, 2023

BUY
$68.3 - $87.44 $98,830 - $126,525
1,447 Added 516.79%
1,727 $129,000
Q3 2022

Oct 05, 2022

BUY
$82.37 - $107.29 $4,612 - $6,008
56 Added 25.0%
280 $23,000
Q2 2022

Jul 11, 2022

SELL
$86.5 - $128.27 $778 - $1,154
-9 Reduced 3.86%
224 $21,000
Q1 2022

Apr 08, 2022

BUY
$101.96 - $128.34 $11,827 - $14,887
116 Added 99.15%
233 $27,000
Q4 2021

Feb 09, 2022

BUY
$106.37 - $130.68 $12,445 - $15,289
117 New
117 $15,000

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $41.9B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track American National Bank Portfolio

Follow American National Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American National Bank, based on Form 13F filings with the SEC.

News

Stay updated on American National Bank with notifications on news.